Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (621-630 of 671) with videos related to

Pageof 68
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantationStefan O Ciurea, Victor Mulanovich, Rima M Saliba, et al.
Blood Advances|August 20, 2024
CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantHusham Sharifi, Christopher D Bertini, Mansour Alkhunaizi, et al.
Transplantation and Cellular Therapy|September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell TransplantationNicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances|December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantationLi Li, Han Chen, David Marin, et al.
Transplantation and Cellular Therapy|July 30, 2021
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical TrialRohtesh S Mehta, Roland Bassett, Julianne Chen, et al.
Science Advances|July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineeringLi Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Leukemia & Lymphoma|October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenanceMahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Frontiers in Oncology|February 22, 2021
Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2Dristhi Ragoonanan, Sajad J Khazal, Rodrigo Mejia, et al.
Pageof 68

Showing results (621-630 of 671) with videos related to

Sort By:
Pageof 68
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantationStefan O Ciurea, Victor Mulanovich, Rima M Saliba, et al.
Blood Advances|August 20, 2024
CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantHusham Sharifi, Christopher D Bertini, Mansour Alkhunaizi, et al.
Transplantation and Cellular Therapy|September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell TransplantationNicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances|December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantationLi Li, Han Chen, David Marin, et al.
Transplantation and Cellular Therapy|July 30, 2021
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical TrialRohtesh S Mehta, Roland Bassett, Julianne Chen, et al.
Science Advances|July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineeringLi Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Leukemia & Lymphoma|October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenanceMahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Frontiers in Oncology|February 22, 2021
Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2Dristhi Ragoonanan, Sajad J Khazal, Rodrigo Mejia, et al.
Pageof 68